[HTML][HTML] Metabolic checkpoints in rheumatoid arthritis
Several studies have highlighted the interplay between metabolism, immunity and
inflammation. Both tissue resident and infiltrating immune cells play a major role in the …
inflammation. Both tissue resident and infiltrating immune cells play a major role in the …
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
F Humby, M Lewis, N Ramamoorthi… - Annals of the …, 2019 - ard.bmj.com
Objectives To unravel the hierarchy of cellular/molecular pathways in the disease tissue of
early, treatment-naïve rheumatoid arthritis (RA) patients and determine their relationship …
early, treatment-naïve rheumatoid arthritis (RA) patients and determine their relationship …
Inflammation across tissues: can shared cell biology help design smarter trials?
T Hosack, T Thomas, R Ravindran, HH Uhlig… - Nature Reviews …, 2023 - nature.com
Immune-mediated inflammatory diseases (IMIDs) are responsible for substantial global
disease burden and associated health-care costs. Traditional models of research and …
disease burden and associated health-care costs. Traditional models of research and …
Identification of a transitional fibroblast function in very early rheumatoid arthritis
Objectives Synovial fibroblasts actively regulate the inflammatory infiltrate by communicating
with neighbouring endothelial cells (EC). Surprisingly, little is known about how the …
with neighbouring endothelial cells (EC). Surprisingly, little is known about how the …
Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren's syndrome
S Nayar, J Campos, CG Smith, V Iannizzotto… - Annals of the …, 2019 - ard.bmj.com
Background The phosphatidylinositol 3-kinase delta isoform (PI3Kδ) belongs to an
intracellular lipid kinase family that regulate lymphocyte metabolism, survival, proliferation …
intracellular lipid kinase family that regulate lymphocyte metabolism, survival, proliferation …
[HTML][HTML] Genetic deletion of the stromal cell marker CD248 (endosialin) protects against the development of renal fibrosis
Background: Tissue fibrosis and microvascular rarefaction are hallmarks of progressive
renal disease. CD248 is a transmembrane glycoprotein expressed by key effector cells …
renal disease. CD248 is a transmembrane glycoprotein expressed by key effector cells …
Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?
SR Aungier, AJ Cartwright, A Schwenzer… - Annals of the …, 2019 - ard.bmj.com
Objectives Controlled immune responses rely on integrated crosstalk between cells and
their microenvironment. We investigated whether targeting proinflammatory signals from the …
their microenvironment. We investigated whether targeting proinflammatory signals from the …
Tissue inflammation signatures point towards resolution in adhesive capsulitis
SIR, Adhesive capsulitis (frozen shoulder) is a remarkable example of a severe, yet self-
limiting, inflammatory and fibrotic condition affecting the shoulder joint capsule. Patients …
limiting, inflammatory and fibrotic condition affecting the shoulder joint capsule. Patients …
Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups
KEN Clark, S Xu, M Attah, VH Ong… - Annals of the …, 2023 - ard.bmj.com
Objectives The severity of skin involvement in diffuse cutaneous systemic sclerosis (dcSSc)
depends on stage of disease and differs between anti-RNA-polymerase III (ARA) and anti …
depends on stage of disease and differs between anti-RNA-polymerase III (ARA) and anti …
Author Correction: Inflammation across tissues: can shared cell biology help design smarter trials?
T Hosack, T Thomas, R Ravindran, HH Uhlig… - Nature Reviews …, 2024 - nature.com
In the version of the article initially published, there were errors in Fig. 1b. The boxes for IL-
23 under “Axial spondyloarthritis” and for CTLA-4 under “Psoriasis” were mistakenly shown …
23 under “Axial spondyloarthritis” and for CTLA-4 under “Psoriasis” were mistakenly shown …